Table 3.
Routine laboratory indices in patient with IBD and non-IBD controls.
| Crohn’s disease (n = 20) | Ulcerative colitis (n = 15) | Non-IBD controls (n = 14) | p value | |
|---|---|---|---|---|
| Haemoglobin, mean (range), g/l | 131 (110–159) | 138 (115–169) | 142 (122–162) | 0.095a |
| White cell count, mean (range), × 109/l | 7.6 (3.5–12.7) | 6.2 (3.0–9.4) | 6.6 (4.5–9.6) | 0.192a |
| Platelet count, mean (range), × 109/l | 269 (151–424) | 255 (140–360) | 223 (129–301) | 0.141a |
| Serum albumin, mean (range), g/l | 39 (28–43) | 41 (36–47) | 40 (35–44) | 0.075a |
| Serum C-reactive protein, median (range), mg/l | 2.0 (<2.0–38) | 2.0 (<2.0–12) | <2.0 (<2.0–7) | 0.264b |
| Faecal calprotectin, median (range), µg/g | 104 (<30–5412) | 83 (<30–96389) | 40 (<30–278)d | 0.112b |
| Log faecal calprotectin, mean (range) | 2.18 (<1.48–3.88) | 2.17 (<1.48–3.92) | 1.74 (<1.48–2.21) | 0.165a |
| 25(OH) vitamin D, mean (range), nmol/l | 67 (26–127) | 65 (14–130) | 65 (24–102) | 0.936a |
a
Analysis of variance.
b
Kruskal–Wallis test.
VDR mRNA expression.
IBD, inflammatory bowel disease; VDR, vitamin D receptor.